Oncolytics Biotech ONCY
NASDAQ ONCY
$0.51 +0.01 (+2.57%)
At close: Oct 21, 2026 · 4:00 PM EDT

Oncolytics Biotech (ONCY) EBT Margin (2010 - 2025)

Updated

Oncolytics Biotech (ONCY) recorded EBT Margin of 762.96% in Q2 2017, up 399.64 percentage points from 363.31% a year earlier.

Analysis

Oncolytics Biotech (ONCY) EBT Margin (2010 - 2025) Analysis & Trends

On a TTM basis, Oncolytics Biotech's EBT Margin came in at 27.22% as of Jun 30, 2017, down 2053.19 percentage points year-over-year; for FY2009, it came in at -5228.79%.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 26.66%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 25.18%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 18.19%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 27.53%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -131.41%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -4.34%
10 Oncolytics Biotech 60.94 Mn 32.05 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -14,652.00%
Jun 30, 2025 -6,949.28%
Dec 31, 2024 -5,259.21%
Sep 30, 2024 -3,651.72%
Jun 30, 2024 -2,106.18%
Dec 31, 2023 -798.77%
Sep 30, 2023 -3,251.80%
Jun 30, 2023 -2,769.29%
Dec 31, 2022 -2,706.05%
Sep 30, 2022 -3,017.81%
Jun 30, 2022 -13,832.65%
Dec 31, 2021 -35,040.91%
Sep 30, 2021 -18,900.51%
Jun 30, 2021 -24,795.15%
Dec 31, 2020 -99.40%
Sep 30, 2020 -50,487.26%
Jun 30, 2020 -20,986.12%
Sep 30, 2019 -7,670.80%
Jun 30, 2019 -9,490.85%
Mar 31, 2019 -9,881.26%
API Access

Oncolytics Biotech EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ONCY&period=max&api_key=YOUR_API_KEY